Treatment of Drug-Eluting Stent Restenosis
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference19 articles.
1. Sirolimus-eluting stent or paclitaxel-eluting stent versus balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial;Kastrati;JAMA,2005
2. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial;Alfonso;J Am Coll Cardiol,2006
3. 17th official report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990–2007);Baz;Rev Esp Cardiol,2008
4. Treatment of patients with in-stent restenosis;Alfonso;EuroIntervention,2009
5. Drug-eluting stent restenosis: the pattern predicts the outcome;Cosgrave;J Am Coll Cardiol,2006
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Off-Label Use of Peripheral Paclitaxel Drug-Coated Balloons in Management of Recurrent Coronary In-Stent Restenosis;Journal of the Society for Cardiovascular Angiography & Interventions;2024-03
2. Risk factors associated with intra‑stent restenosis after percutaneous coronary intervention;Experimental and Therapeutic Medicine;2021-08-09
3. Magnesium alloy stents: A friend or foe of coronary in-stent restenosis?;Materials Express;2021-05-01
4. Development of a nanosensor-integrated stent for wireless, continuous monitoring of restenosis progression;Nano-, Bio-, Info-Tech Sensors and Wearable Systems;2021-03-22
5. Trial sequential analysis of studies comparing the frequency of target-vessel revascularization with drug-coated balloons as compared with second-generation drug-eluting stents in coronary in-stent restenosis: Have we generated enough evidence in the field?;Indian Heart Journal;2019-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3